About Us
Our Approach
- Overview
- Scientific Presentations & Publications
Pipeline
Clinical Trials
- CUE-101-01 HPV16+ HEAD AND NECK CANCER
Investor & Media
Partnering
Careers
- Overview
- Current Openings
Contact Us

Publications

In vivo detection of antigen-specific CD8+ T cells by immuno-positron emission tomography

« Go Back

Overview
Leadership
Founders
Board of Directors
Scientific Advisory Board

Overview

Overview
Immuno-Oncology
Chronic Infectious Disease
Autoimmune Disease

Overview
News Releases
Stock Information
Events and Presentations
Financial Information
Corporate Governance
FAQs
Email Alerts

Overview
Current Openings

Cue Biopharma
21 Erie Street
Cambridge, MA 02139

TEL 617-949-2680

Business Development: BD@cuebio.com
Media: media@cuebio.com
Investor Relations: IR@cuebio.com

Legal | Privacy | Cookies

© 2021 Cue Biopharma. All rights reserved
The name Cue Biopharma, our logo, the tagline "Immune Responses, On Cue," the Cue Biologics name, "Immuno-STAT" and "Immuno-STAT Biologics" are all trademarks of Cue Biopharma, Inc.

About Us
Our Approach
- Overview
- Scientific Presentations & Publications
Pipeline
Clinical Trials
- CUE-101-01 HPV16+ HEAD AND NECK CANCER
Investor & Media
Partnering
Careers
- Overview
- Current Openings
Contact Us